Intraarterial hepatic chemotherapy with fluorouracil, fluorodeoxyuridine, mitomycin C, cisplatin or methotrexate as single-agent anticancer drugs for a transplanted experimental liver tumor in rats

Journal of Cancer Research and Clinical Oncology

Volumn 122, Issue 7, 1996, Pages 421-426

  Kurth, S ^a   Bulian, D ^a   Kreft, B ^a   Riemenschneider, Th ^b  

^a UNIVERSITY OF BONN   (Germany)

^b DRK Krankenhaus Neuwied   (Germany)

Author keywords

Drug therapy; Experimental liver neoplasm; Intraarterial

Indexed keywords

CISPLATIN; FLOXURIDINE; FLUOROURACIL; METHOTREXATE; MITOMYCIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRAFT; CONTROLLED STUDY; INTRAARTERIAL DRUG ADMINISTRATION; LIVER CELL CARCINOMA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANGIOGRAPHY; ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOXURIDINE; FLUOROURACIL; INJECTIONS, INTRA-ARTERIAL; LIVER NEOPLASMS, EXPERIMENTAL; MALE; METHOTREXATE; MITOMYCIN; NEOPLASM TRANSPLANTATION; PROSPECTIVE STUDIES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0029882051     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01212882     Document Type: Article

References (49)

1. Aigner KR, Walther H, Helling HJ, Link KH (1985) Die isolierte Leberperfusion. Beitr Onkol 21:43-83
2. Bartkowski R, Berger MR, Aguiar JLA, Henne TH, Dörsam J, Geelhaar GH, Schlag P, Herfarth C (1986) Experiments on the efficacy and toxicity of locoregional chemotherapy of liver tumors with 5-fluoro-2′-deoxyuridine (FUDR) and 5-fluorouracil (5-FU) in an animal model. J Cancer Res Clin Oncol 111:42-46
3. Bassermann R (1984) Angiogenese und Vaskularisation in Metastasen. Verh Dtsch Ges Pathol 68:124-139
4. Biermann HR (1951) Intra-arterial-catheterization of viscera in man. Am J Roentgenol 66:555-562
5. Birns M (1960) An ascites tumor derived from the Novikoff Hepatoma. J Natl Cancer Inst 25:547-555
6. Bleyer WA (1978) The clinical pharmacology of methotrexate. New applications of an old drug. Cancer 41:36-51
7. Breedis C, Young G (1954) The blood supply of neoplasms in the liver. Am J Pathol 30:969-985]
8. Breithaupt H (1982) Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate following infusions of high-dose methotrexate. Cancer Treat Rep 66:1733-1741
9. Cady B (1983) Natural history of primary and secondary tumors of the liver. Semin Oncol 10:127-134
10. Carlsson G, Gullberg B, Hafström L (1983) Estimation of liver tumor volume using different formulas - an experimental study in rats. J Cancer Res Clin Oncol 105:20-23
11. Crooke ST, Bradner WT (1976) Mitomycin C: a review. Cancer Treat Rev 3:121-139
12. Demmel M (1993) Locoregionäre Chemotherapie von experimentellen Lebertransplantationstumoren mit Microsphären. Dissertation Bonn
13. Di Bisceglie AM (1988) Hepatocellular carcinoma. Ann Int Med 108:390-401
14. Eble MJ, Gademann G, Wannenmacher M (1993) The value of radio-therapy for liver metastases. Strahlenther Onkol 169:459-468
15. Eckman WW, Patlak CS, Fenstermacher JD (1974) A critical evaluation of principles governing the advantages of intra-arterial infusions. J Pharmacocinetics Biopharmaceutics 2:257-285
16. Eichler O, FArah A, Herken H, Welch AD (eds) (1975) Handbook of experimental pharmacology XXXVIII. 1,2. Antineoplastic drugs, Springer, Berlin Heidelberg New York
17. Ensminger W, Rosowsky A, Raso V, Levin DC, Glode M, Come S, Steele G, Frei E III (1978) A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2-deoxyuridine and 5-fluorouracil. Cancer Res 38:3784-3792
18. Evans RM, Laskin JD, Hakala MT (1981) Excess of folates and deoxyinosine on the activity an dthe site of action of fluorouracil. Cancer Res 41:3288
19. Fortuny IE, Theologides A, Kennedy BJ (1975) Hepatic arterial infusion for liver metastases from colorectal cancer: comparison of mitomycin C (NSC-26980) and 5-fluorouracil (NSC-19893). Cancer Chemother Rep 59:401-404
20. Fraile RJ, Baker LH, Buroker TR, Horwitz J, Vaitkevicius VK (1980) Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion. Cancer Res 40:2223-2228
21. Gorgun B, Watne AL (1967) Infusiontherapy in hepatoma and metastatic liver tumors. Am J Surg 113:363-368
22. Greenway B (1988) Hepatic metastases from colorectal cancer: resection or not. Br J Surg 75:513-519
23. Gyves J (1985) Pharmacoloty of intraperitoneal infusion of 5-fluorouracil and mitomycin-C. Semin Oncol 12:29-32
24. Hohenberger P, Strauss LG, Lehner B, Frohmuller S, Dimitrakopoulou, Schlag P (1993) Perfusion of colorectal liver metastases and uptake of fluorouracil assessed by H2(15)O and (18F)uracil positron emission tomography (PET). Eur J Cancer 29A: 1682-1686
25. Hohn DC, Rayner AA, Economou JS, Ignoffo RJ, Lewis BJ, Stagg RJ (1986) Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion. Cancer 57:465-170
26. Jain RK (1988) Determinants of tumor blood flow: A review. Cancer Res 48:2641-2658
27. Kajanti M, Rissanen P, Virkkunen P, Franssila K, Mäntylä M (1986) Regional intra-arterial infusion of cisplatin in primary hepatocellular carcinoma. Cancer 58:2386-2388
28. Kemeny N (1983) The systemic chemotherapy of hepatic metastases. Semin Oncol 10:148-158
29. Kemeny N (1990) Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer. J Clin Oncol 8:313-318
30. Kemeny NE (1992) Is hepatic infusion of chemotherapy effective treatment for liver metastases? Yes! Adv Oncol:207-227
31. Kemeny N, Cohen A, Seiter K, Conti JA, Sigurdson ER, Tao Y, Niedzwiecki D, Botet J, Budd A (1993) Randomized trial of hepatic arterial floxuridine, mitomycin and carmustine versus floxuridine allone in colorectal cancer. J Clin Oncol 11:330-335
32. Lang W (1984) Geographical pathology and epidemiology of liver tumours. Verh Dtsch KrebsGes 5:437-442
33. Mäkelä JT, Kantola R, Kairaluoma MI (1993) Superselective intraarterial chemotherapy with mitomycin C for hepatocellular carcinoma. Surg Oncol 2:99-104
34. Mandel HG (1969) The incorporation of 5-fluorouracil in the RNA and its molecular consequences. Proc Mol Subcell Biol 1:82
35. Naser-Hijazi B, Berger MR, Schmahl D, Schlag P, Hull WE (1991) Locoregional administration of 5-fluoro-2′-deoxyuridine (EdUrd) in Novikoff hepatoma in the rat: effects of the dose and infusion time on tumor growth and on FdUrd metabolite levels in tumor tissue as determined by 19F-NMR spectroscopy. J Cancer Res Clin Oncol 117:295-304
36. Nilsson LAV, Zettergren L (1967) Blood supply and vascular pattern of induced primary hepatic carcinoma in rats. Acta Pathol Microbiol Scand 71:179-186
37. Novikoff AB (1957) A transplantable rat liver tumor induced by 4-dimethylaminoazobenzene. Cancer Res 17:1010-1027
38. Patt YZ (1993) Regional hepatic arterial chemotherapy for colorectal cancer metastatic to the liver: the controversy continues. J Clin Oncol 11:815-819
39. Riemenschneider T, Ruf C, Späth G, Stuhldreier G, Elmouaouy A (1988) Continuous or bolus chemotherapy with 5-fluoro-2′-deoxyuridine in transplanted experimental liver tumors. J Cancer Res Clin Oncol 114:482-486
40. Rivkin SE, Johnson L (1985) The use of the surgically implanted "infusaid" pump for ambulatory outpatient hepatic arterial chemotherapy for patients with colon cancer metastatic to the liver. Proc Am Soc Clin Oncol 4:83, C-322
41. Rosenberg B (1985) Fundamental studies with cisplatin. Cancer 55:2303-2316
42. Segall HN (1953) An experimental anatomical investigation of the blood and bill channels of the liver. Surg Gynecol Obstet 37:152-178
43. Stagg RJ, Lewis BJ, Friedman MA, Ignoffo RJ, Hohn DC (1984) Hepatic arterial chemotherapy for colorcetal cancer metastastic to the liver. Ann Int Med 100:736-743
44. Toyoda H, Nakano S, Kumada T, Takeda I, Sugiyama K, Osada T, Kiriyama S, Suga T, Takahashi M, Hayashi K, et al (1994) Analysis of methods of administration on local arterial infusion chemotherapy for severe advanced hepatocellular carcinoma. Gan To Kagaku Ryoho 21:2202-2205
45. Uozumi J, Sagiyama K, Aoki K, Iwamoto Y, Baba T (1983) Effectiveness of "two-route chemotherapy" using cisplatin and its antidote, sodium thiosulfate, on lifespan of rats bearing metastatic liver tumors. Cancer Treat Rep 67:1067-1074
46. Vexler AM, Mou X, Gabizon AA, Gorodetsky R (1995) Reduction of the systemic toxicity of cisplatin by intra-arterial hepatic route administration for liver malignancies. Int J Cancer 60:611-615
47. Vogel CL, Adamson RH, DeVita VT, Johns DG, Kyalwazi SK (1972) Preliminary clinical trial of dichloromethotrexate (NSC-29630) in hepatocellular carcinoma. Cancer Chemother Rep 56:249-258
48. Watkins E, Sullivan RD (1964) Cancer chemotherapy by prolonged arterial infusion. Surg Gynecol Obstet 118:3-19
49. Yonemura Y, Matuki N, Sakuma H, Katayuma K, Sawa T, Fujimura T, Ohyama S, Miwa K, Miyazaki I, Tanaka M, Sasaki T (1992) Effect of intra-hepatoarterial infusion of MMC and CDDP for gastric cancer patients with liver metastases. Jpn J Surg 22:253-259